重组传染性支气管炎病毒H120基疫苗在肉中的构造和免疫性评估
Ali Nayef1, Sara Jibreen1, Mustafa Ababneh2
1Department of Research and Development, The Arab Pesticides and Veterinary Drugs Manufacturing Company, El-Hassan Industrial Estate, Ar-Ramtha 11193, Jordan.
Animals : an open access journal from MDPI
|January 28, 2026
概括
一种新的传染性支气管炎病毒 (IBV) 候选疫苗,rH120,是使用金门组装开发的. 这种重组病毒在中显示出高效的复制和更强的免疫反应,为IBV控制提供了一个有前途的工具.
科学领域:
- 兽医病毒学 兽医病毒学
- 分子生物学分子生物学
- 疫苗开发 疫苗开发
背景情况:
- 传染性支气管炎病毒 (IBV) 在家禽中造成重大经济损失.
- 目前的IBV疫苗对不断演变的菌株提供有限的保护.
- 对抗IBV的新型疫苗策略非常需要.
研究的目的:
- 使用金门组装 (GGA) 开发一种复合IBV (rH120).
- 评估rH120.的复制,遗传稳定性和免疫性.
- 评估基于GGA的反向遗传学的潜力,以促进IBV疫苗的发展.
主要方法:
- 完整的IBV H120基因组通过GGA合成并组装成12个片段.
- 重组病毒 (rH120) 救援是在肉纤维细胞中进行的.
- 复制动力学,病毒RNA检测和抗体反应在胚胎SPF卵和肉中进行了分析.
主要成果:
- 成功地救出并传播传染性rH120.
- rH120在胚胎卵中表现出与野生型H120菌株相似的复制动力学.
- rH120在肉中表现出高效的复制,并在感染后的14天内诱导出更强大的抗体反应.
- 证实rH120病毒具有基因稳定性,传染性和免疫性.
结论:
- 金门组合是一种有效的IBV逆遗传系统.
- 开发的rH120显示出作为感染性支气管炎病毒的疫苗候选人的承诺.
- 这种方法有助于开发针对新出现的IBV变种的改进疫苗.
相关概念视频
Vaccinations
51.5K
Overview
51.5K
Viral Recombination
25.1K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.1K
Recombinant DNA
102.5K
Overview
102.5K
Homologous Recombination
62.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.9K
What are Viruses?
128.0K
Overview
128.0K
Cancer Vaccines
1.0K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.0K


